![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](om2121contents.gif)
Acta Cryst. (2007). E63, m1930 [ doi:10.1107/S1600536807028322 ]
N]bis(salicylato-
O)zinc(II)Abstract: The reaction of Zn(CH3COO)2 with 4-(dimethylamino)pyridine (DMAP) and salicylic acid in a 1:2:2 molar ratio affords the title complex, [Zn(C7H5O3)2(C7H10N2)2]. The ZnII atom resides on a twofold rotation axis and is tetrahedrally coordinated by two DMAP ligands and two salicylate anions in a distorted tetrahedral geometry.
Online 20 June 2007
Copyright © International Union of Crystallography
IUCr Webmaster